As of 2024-12-15, the EV/EBITDA ratio of THC Biomed Intl Ltd (THC.CN) is -3.07. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. THC.CN's latest enterprise value is 6.24 mil CAD. THC.CN's TTM EBITDA according to its financial statements is -2.03 mil CAD. Dividing these 2 quantities gives us the above THC.CN EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 15.8x - 24.9x | 20.4x |
| Forward P/E multiples | 15.8x - 24.9x | 20.4x |
| Fair Price | (0.45) - 0.28 | (0.17) |
| Upside | -2343.8% - 1324.9% | -945.8% |
| Date | EV/EBITDA |